Multimodal Treatment of Pediatric Pain to Avoid Addiction and Opioid Use Disorder

Multi-modal Treatment of Pediatric Pain to Avoid Addiction and Opioid Use Disorder



The MATE (Medication Access and Training Expansion) Act requires new or renewing DEA licensees (prescribers of Schedule II – V controlled substances) to complete eight (8) hours of training on the treatment and management of patients with substance use disorders. This eight-hour online course specific to pediatric practice was recorded from the 12th Annual Pediatric Pain Master Class and aims to address the lack of formal training in pediatric pain management.

Study at your own pace with eight videos focused on multimodal analgesia adjuvant analgesia; chronic pain in head, abdomen, muscles and joints; avoiding anxiety during needle procedures; opioid mitigation; substance use disorder; and cannabis and cannabinoids. Optional content in neuropathic pain and needle pain prevention is also available.

This CME opportunity meets the SAMHSA Medication Access and Training Expansion (MATE) Act 8-hour DEA licensing or renewal training requirement.

OBJECTIVES

Upon completion of this activity, the participant will be able to:

1. Use an evidence-based approach to multimodal analgesia in children
2. Explain the optimal approach to chronic pain in children
3. Describe the essential five “bundled” components of needle pain management
4. Develop strategies to identify youth and families at risk for opioid related adverse outcomes and approaches to reduce these risks
5. Develop strategies to diagnose and treat pediatric/adolescent substance use disorder
6. Describe components of successful chronic pain management without opioids and further testing/imaging in pediatric patients with chronic pain
7. Compare the effectiveness and harms of cannabinoids in treatment of pediatric pain

PROGRAM

1. Multimodal Analgesia: Advanced Pediatric Pain Treatment and Prevention
2. Primary Pain Disorders: Chronic Pain in Head, Abdomen, Muscles, and Joints ^RX
3. Avoiding Pain and Anxiety Caused by Needle Procedures ^RX
4. Mitigating the Risks of Prescription Opioids for Children & Adolescents ^{RX, II}
5. Approaching Substance Use in Pediatric Pain Settings ^{RX, II}
6. Explaining Chronic Pain to Kids and their Parents
7. Cannabis and Cannabinoids for Pediatric Pain: Are they Safe and Efficacious?
8. OPTIONAL: Neuropathic Pain and Use of Adjuvant Analgesia (non-credit)
9. OPTIONAL: The Children's Comfort Promise: Using Improvement Methodology to Bring Evidence to the Bedside (non-credit)

RX = Applicable to pharmacotherapeutics credit for nurses.
II = Applicable to Schedule II Drug credits.

FEES

The cost to participate in this activity is $75.00.

Cancellations and Refunds: Cancellations should be made in writing within 7 days of enrollment. Refunds will only be made in the event that technical difficulties prevent completion of the activity, or if no interaction with the material occurred because of inadvertent or mistaken enrollment, or expiration of the activity before the learner had the opportunity to complete it fully. Fees can be transferred to another activity in the case of mistaken enrollment.


AVAILABILITY
Released: December 1, 2023; Expires; November 30, 2026

COURSE DIRECTOR

Stefan Friedrichsdorf, MD, FAAP
Professor of Pediatrics
University of California, San Francisco

ORGANIZING COMMITTEE

Jeffrey Tabas, MD
Professor of Emergency Medicine
Zuckerberg San Francisco General Hospital and Trauma Center

Tymothi Peters
Director, Office of Continuing Medical Education

Joey Bernal, MA
Manager, Continuing Certification and Special Projects

FACULTY

Donna Eull, PhD, MA, RN, CHPPN
Clinical Associate Professor
University of Minnesota School of Nursing
Minneapolis, Minnesota

Stefan Friedrichsdorf, MD, FAAP
Professor of Pediatrics
University of California, San Francisco

Lucien Gonzalez, MD, MS, FAAP
Associate Professor, General Pediatrics & Adolescent Medicine
University of North Carolina School of Medicine
Chapel Hill, North Carolina

Terri Voepel-Lewis, PhD, RN, FAAN
Associate Research Scientist
Department of Anesthesiology
Michigan Medicine, University of Michigan
Ann Arbor, Michigan

DISCLOSURE

None of the content planners, staff, reviewers, nor others in control of content has disclosed relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION

In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: UCSF designates this enduring material for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

>> Please see information concerning Maintenance of Certification/Continuing Certification Credit below.

Nurse Practitioners and Registered Nurses: This course is available for 8.00 Nurse Contact Hours as designated by the ANCC. This activity is designated for a maximum of 5.25 pharmacotherapeutic hours (0.525 CEU's) towards meeting the requirement for nursing pharmacology continuing education. Nurses should claim 0.1 CEUs for each contact hour of participation in designated pharmacotherapeutic continuing education.

Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.

Pharmacists: This activity has been approved for 8.0 contact hours under the Universal Activity Number JA0000302-0000-230002-H08-P. Credits will be reported to CPE Monitor within 2-3 weeks of completion of the course.

California Psychologists: This educational activity is recognized by the California Board of Psychology as meeting the continuing education requirements toward license renewal for California psychologists. Psychologists are responsible for reporting their own attendance to the California Board of Psychology. Psychologists from other states should check with their respective licensing boards.

This CME/CE opportunity meets the Medication Access and Training Expansion (MATE) Act requirements from the Substance Abuse and Mental Health Services Administration (SAMHSA) for Drug Enforcement Administration (DEA) training on substance use disorders. Providers planning to receive or renew their DEA registration can earn 8.0 hours towards their one-time eight-hour MATE requirement by completing the entire activity.

This CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural and linguistic competency.

Approved credits include 8.0 toward meeting the requirement under California Assembly Bill 487, Pain Management and End-of-Life Care.

CLAIMING CREDIT

Participants must view the online recordings and complete the evaluation form online to receive a certificate. Your certificate will be available immediately for print or download upon completion of the entire activity. Certificates are not proof of participation for pharmacists; credits will be reported through CPE Monitor.

Maintenance of Certification / Continuing Certification Information

Successful completion of this CME activity, which includes participation in the evaluation
component, enables the participant to earn up to 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting any of the MOC credits listed above. You must provide your diplomate number and month and day of birth to claim MOC/CC points.

RESOURCES

Cultural and Linguistic Competency Resources
CLC Info and Resources

UC Online Privacy Policy
http://meded.ucsf.edu/cme/privacy-policy

A WELCOME CHANGE

This online course has been relocated to our new UCSF CE Portal, hosted by CloudCME, at https://ucsf.cloud-cme.com. Your account in our current system has been transferred to the new Portal; however, you will need to update your password to access it. Any credits you have earned here have been transferred or will be soon.

Next Steps:

Navigate to the site above and select SIGN IN from the menu bar. Enter your email address and select Forgot Your Password? to finish setting up your new account.

Select MY CME from the menu bar to update your profile – confirm your degree(s) and profession(s) are correct to ensure you receive the appropriate credit.

For more information on the new CE Portal, visit https://ucsf.cloud-cme.com/content/learners for tips on getting started and navigating the new system.

Go directly to this course in the Portal to register.

UCSF Office of CME believes you will enjoy the enhanced functionality and ease of use of the new platform, and we would love to hear your feedback. If you would like to share any feedback, have questions, encounter issues with logging in, or require additional support, please contact us by submitting a Support Ticket.

Note: If you have already started the course on the current platform, you must complete it before May 1, 2026, to earn credit. If you have registered, but have not started, your registration has been transferred. We encourage you to start the course on the new platform.